Helsinn, a privately owned pharmaceutical group has an extensive portfolio of marketed cancer care products and a robust development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values: respect, integrity, quality, through a unique licensing business model and working with long standing partners in pharmaceuticals, biotecnology, medical devices, nutritional supplements. Headquartered in Switzerland, Helsinn has manufacturing sites in Switzerland & Ireland, and operating subsidiaries in Ireland, the U.S., Monaco and China.